The European Association of Authorized Representative (EAAR) welcomes the extension for the MDR compliance of legacy products and fully supports a fast implementation. It will allow for a smoother transition in particular for small and medium size manufacturers.
EEA
EAAR (European Association of Authorized Representatives)
Industry association · Belgium
2
positions filed
in the 655 files tracked
2
legislative files
of 655 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 655 consultation files tracked so far (56,999 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track EAAR in PolicySpeak: request access →
Work at EAAR (European Association of Authorized Representatives)? so we know who speaks for it.
Their record over time
EAAR (European Association of Authorized Representatives) filed 2 positions between 11 Dec 2022 and 18 Jan 2023, across 2 of the 655 legislative files tracked here, attaching a full position paper 1 time.
2022 · 1 filed2023 · 1 filed
What they argued
REVISION OF THE PRODUCT LIABILITY DIRECTIVE EAAR POSITION PAPER The European Association of Authorized Representatives (EAAR), operating in the medical devices sector, would like to thank the European Commission for giving the stakeholders the opportunity to comment on the Proposal for revision of the Product Liability Directive (PLD).
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put EAAR (European Association of Authorized Representatives) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Is this your organization?
Everything on this page comes from EAAR (European Association of Authorized Representatives)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.